Updates on recent FDA approvals, label expansions, and regulatory decisions that may affect everyday oncology practice.
Updates on recent FDA approvals, label expansions, and regulatory decisions that may affect everyday oncology practice.
FDA approves D-VRd quadruplet for transplant-ineligible newly diagnosed multiple myeloma based on CEPHEUS trial PFS and MRD negativity gains.
